Changes in biochemical markers of hyperplastic and malignant prostatic tissues

Area of Science:

• Biochemistry
• Urology
• Oncology

Background:

• Benign prostatic hyperplasia (BPH) is a common condition in aging men.
• Biochemical alterations in prostate tissue are associated with BPH development and progression.
• Understanding these changes can aid in diagnosis and treatment strategies.

Purpose of the Study:

• To evaluate specific biochemical markers in human prostatic tissue from patients with benign hyperplasia.
• To compare these markers with those in normal and malignant prostatic tissues.
• To investigate the relationship between acid phosphatase activity and citric acid concentration in BPH.

Main Methods:

• Analysis of human prostatic tissue samples from patients with benign hyperplasia and normal men.
• Assay of acid phosphatase and aminopeptidase enzyme activities.
• Quantification of citric acid, zinc, and calcium content in prostatic tissue.

Main Results:

• Acid phosphatase activity was significantly elevated (nearly threefold) in benign hyperplastic prostates compared to normal controls.
• Citric acid concentration, zinc, and calcium levels were significantly increased in BPH tissues (p < 0.001).
• Acid phosphatase activity changes correlated directly with citric acid concentration.
• Aminopeptidase activity showed no change in BPH and was lower in malignant tissues.

Conclusions:

• Benign prostatic hyperplasia is characterized by distinct biochemical changes, including elevated acid phosphatase, citric acid, zinc, and calcium.
• These findings highlight potential biomarkers for BPH.
• Further research is warranted to explore the clinical implications of these biochemical alterations.